These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
377 related articles for article (PubMed ID: 16024603)
1. Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. Jansen AP; Camalier CE; Colburn NH Cancer Res; 2005 Jul; 65(14):6034-41. PubMed ID: 16024603 [TBL] [Abstract][Full Text] [Related]
2. Targeted expression of bcl-2 to murine basal epidermal keratinocytes results in paradoxical retardation of ultraviolet- and chemical-induced tumorigenesis. Rossiter H; Beissert S; Mayer C; Schön MP; Wienrich BG; Tschachler E; Kupper TS Cancer Res; 2001 May; 61(9):3619-26. PubMed ID: 11325830 [TBL] [Abstract][Full Text] [Related]
3. Difluoromethylornithine chemoprevention of epidermal carcinogenesis in K14-HPV16 transgenic mice. Arbeit JM; Riley RR; Huey B; Porter C; Kelloff G; Lubet R; Ward JM; Pinkel D Cancer Res; 1999 Aug; 59(15):3610-20. PubMed ID: 10446971 [TBL] [Abstract][Full Text] [Related]
4. A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation. Yang HS; Jansen AP; Nair R; Shibahara K; Verma AK; Cmarik JL; Colburn NH Oncogene; 2001 Feb; 20(6):669-76. PubMed ID: 11314000 [TBL] [Abstract][Full Text] [Related]
5. Linoleic acid metabolite suppresses skin inflammation and tumor promotion in mice: possible roles of programmed cell death 4 induction. Yasuda M; Nishizawa T; Ohigashi H; Tanaka T; Hou DX; Colburn NH; Murakami A Carcinogenesis; 2009 Jul; 30(7):1209-16. PubMed ID: 19414503 [TBL] [Abstract][Full Text] [Related]
6. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development. Kiguchi K; Bol D; Carbajal S; Beltrán L; Moats S; Chan K; Jorcano J; DiGiovanni J Oncogene; 2000 Aug; 19(37):4243-54. PubMed ID: 10980598 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice. Zhou HM; Bolon I; Nichols A; Wohlwend A; Vassalli JD Cancer Res; 2001 Feb; 61(3):970-6. PubMed ID: 11221892 [TBL] [Abstract][Full Text] [Related]
8. Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis. Honeycutt KA; Chen Z; Koster MI; Miers M; Nuchtern J; Hicks J; Roop DR; Shohet JM Oncogene; 2006 Jul; 25(29):4027-32. PubMed ID: 16518415 [TBL] [Abstract][Full Text] [Related]
9. Protein kinase Cdelta-mediated signal to ornithine decarboxylase induction is independent of skin tumor suppression. Wheeler DL; Reddig PJ; Dreckschmidt NE; Leitges M; Verma AK Oncogene; 2002 May; 21(22):3620-30. PubMed ID: 12032864 [TBL] [Abstract][Full Text] [Related]
10. Calgranulins S100A8 and S100A9 are negatively regulated by glucocorticoids in a c-Fos-dependent manner and overexpressed throughout skin carcinogenesis. Gebhardt C; Breitenbach U; Tuckermann JP; Dittrich BT; Richter KH; Angel P Oncogene; 2002 Jun; 21(27):4266-76. PubMed ID: 12082614 [TBL] [Abstract][Full Text] [Related]
11. Altered expression of insulin-like growth factor I and its receptor during multistage carcinogenesis in mouse skin. Rho O; Bol DK; You J; Beltrán L; Rupp T; DiGiovanni J Mol Carcinog; 1996 Oct; 17(2):62-9. PubMed ID: 8890954 [TBL] [Abstract][Full Text] [Related]
12. Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis. La E; Muga SJ; Locniskar MF; Fischer SM Mol Carcinog; 1999 Apr; 24(4):276-86. PubMed ID: 10326864 [TBL] [Abstract][Full Text] [Related]
13. Aerosol-delivered programmed cell death 4 enhanced apoptosis, controlled cell cycle and suppressed AP-1 activity in the lungs of AP-1 luciferase reporter mice. Hwang SK; Jin H; Kwon JT; Chang SH; Kim TH; Cho CS; Lee KH; Young MR; Colburn NH; Beck GR; Yang HS; Cho MH Gene Ther; 2007 Sep; 14(18):1353-61. PubMed ID: 17611588 [TBL] [Abstract][Full Text] [Related]
14. Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis. Chan KS; Sano S; Kataoka K; Abel E; Carbajal S; Beltran L; Clifford J; Peavey M; Shen J; Digiovanni J Oncogene; 2008 Feb; 27(8):1087-94. PubMed ID: 17700521 [TBL] [Abstract][Full Text] [Related]
15. Influence of beta1 integrins on epidermal squamous cell carcinoma formation in a transgenic mouse model: alpha3beta1, but not alpha2beta1, suppresses malignant conversion. Owens DM; Watt FM Cancer Res; 2001 Jul; 61(13):5248-54. PubMed ID: 11431366 [TBL] [Abstract][Full Text] [Related]
16. Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression. Allen SM; Florell SR; Hanks AN; Alexander A; Diedrich MJ; Altieri DC; Grossman D Cancer Res; 2003 Feb; 63(3):567-72. PubMed ID: 12566297 [TBL] [Abstract][Full Text] [Related]
17. PTEN loss promotes rasHa-mediated papillomatogenesis via dual up-regulation of AKT activity and cell cycle deregulation but malignant conversion proceeds via PTEN-associated pathways. Yao D; Alexander CL; Quinn JA; Porter MJ; Wu H; Greenhalgh DA Cancer Res; 2006 Feb; 66(3):1302-12. PubMed ID: 16452183 [TBL] [Abstract][Full Text] [Related]
18. Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation. Yang HS; Knies JL; Stark C; Colburn NH Oncogene; 2003 Jun; 22(24):3712-20. PubMed ID: 12802278 [TBL] [Abstract][Full Text] [Related]
19. Genetic deletion of p21WAF1 enhances papilloma formation but not malignant conversion in experimental mouse skin carcinogenesis. Weinberg WC; Fernandez-Salas E; Morgan DL; Shalizi A; Mirosh E; Stanulis E; Deng C; Hennings H; Yuspa SH Cancer Res; 1999 May; 59(9):2050-4. PubMed ID: 10232585 [TBL] [Abstract][Full Text] [Related]
20. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mouse epidermis coexpressing transforming growth factor-alpha and v-fos: acceleration of autonomous papilloma formation and malignant conversion via c-Ha-ras activation. Wang XJ; Liefer KM; Greenhalgh DA; Roop DR Mol Carcinog; 1999 Dec; 26(4):305-11. PubMed ID: 10569807 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]